Executive Summary: Apollo Hospitals Enterprise Scorecard

Integrated Business Model Architecture

APOLLO HOSPITALS INTEGRATED HEALTHCARE ECOSYSTEM
Healthcare Services ──► 10,000+ Beds across 70+ Tertiary & Quaternary Hospitals.
Apollo HealthCo ──► Omnichannel Apollo 24/7 Digital Platform + 6,000+ Pharmacy Outlets.
Health & Lifestyle ──► AHLL: Primary Clinics, Cradle Maternity, Diagnostics & Day Surgery.
 Advanced Medical Tech ──► Proton Beam Therapy, AI Oncology, & Robotic Surgery Systems.

Founded by Dr. Prathap C. Reddy, Apollo Hospitals Enterprise Limited operates across three core business verticals:

1. Healthcare Services (Hospitals): The core profit engine comprising 10,000+ operational beds across 70+ hospitals, offering advanced tertiary and quaternary care in cardiology, oncology, neurology, orthopedics, and organ transplantation.
2. Apollo HealthCo (Digital & Retail Pharmacy): Combines India's largest retail pharmacy network (6,000+ stores) with the Apollo 24/7 digital healthcare platform, creating an omnichannel ecosystem for online doctor consultations, medicine delivery, and diagnostic bookings.
3. Apollo Health & Lifestyle Limited (AHLL): Manages primary care clinics, Apollo Diagnostics, Apollo Cradle (maternity), and Apollo Spectra (short-stay surgery centers).

Fundamental Financial Analysis (Q1 FY27 & Multi-Year Growth)

Key Financial Highlights (Q1 FY27 / June 2026 Quarter):

• Revenue Outperformance: Consolidated revenue grew +21.0% YoY to ₹7,043.50 Crore, supported by higher inpatient occupancy and digital pharmacy expansion.
• Profitability Expansion: Net profit after tax (PAT) jumped +38.41% YoY to ₹610.40 Crore, driven by operating leverage in healthcare services and reduced cash burn in Apollo 24/7.
• EBITDA Acceleration: Consolidated quarterly EBITDA expanded +28.0% YoY to ₹1,092.00 Crore, reflecting margin improvement across mature hospital clusters. Track complete fundamental breakdowns on Investalks.in Fundamental Analysis.

Operational Efficiency Metrics (ARPOB, Occupancy & Bed Expansion)

OPERATIONAL EFFICIENCY MATRIX
ARPOB Growth: +11.0% YoY  ──► Driven by complex surgeries & repricing with insurance payers.
Bed Occupancy: ~68% – 72% ──► High asset utilization across mature metro hospital hubs.
5,800+ Bed Pipeline  ──► Adding capacity in Gurugram, Hyderabad, Kolkata, & Pune.

1. ARPOB Expansion (+11.0% YoY): Average Revenue Per Occupied Bed reached ~₹59,500 per day, driven by an increased proportion of high-margin quaternary surgeries (robotic oncology, liver/kidney transplants, and advanced cardiology).
2. Occupancy Stability: Hospital bed occupancy held firm at ~68% to 72%, indicating strong patient demand.
3. 5,800+ Bed Expansion Pipeline: Over the next 4 to 5 years, Apollo plans to add 5,800+ beds via greenfield and brownfield projects, expanding footprint in NCR Gurugram, Hyderabad, Kolkata, Bangalore, and Pune.

Apollo HealthCo Demerger & Value Unlocking Strategy

• Strategic Rationale: Apollo is reorganizing its digital health platform (Apollo 24/7), retail pharmacy business, and wholesale distributor Keimed into a streamlined subsidiary: Apollo HealthCo.
• Listing Timeline: Management guidance targets the demerger and separate listing of Apollo HealthCo on the NSE/BSE around Q4 FY27 (December 2026 – March 2027).
• Value Creation: The demerger will allow market participants to value the hospital business and retail/digital pharmacy assets independently, driving potential re-rating for existing shareholders.

Multi-Timeframe Technical Chart Analysis & Indicators

TECHNICAL CHART LEVEL MAPPING (NSE: APOLLOHOSP)
    ₹9,326.80 ── 52-Week Intraday High
    ₹8,784.00 === CURRENT SPOT: ~₹8,784
    ₹8,650.00 ── 20-Day EMA Dynamic Support
    ₹8,350.00 ── 50-Day EMA Major Structural Base
    ₹8,020.00 ── 100-Day EMA Long-Term Cushion

A. Moving Average Ribbons (EMA Confluence):

• 20-Day EMA: Sits at ₹8,650.00, providing immediate short-term support.
• 50-Day EMA: Sits at ₹8,350.00, acting as the primary trend baseline.
• 100-Day EMA: Sits at ₹8,020.00.
• 200-Day EMA: Sits at ₹7,550.00, establishing the macro long-term floor.

B. Momentum Oscillators:

• Relative Strength Index (RSI 14): Daily RSI stands at 58.40, indicating healthy bullish strength without reaching overbought levels (>75).
• MACD (12, 26, 9): Histogram shows positive expansion above the Signal Line, confirming upward momentum. Explore technical chart guides on Investalks.in Technical Indicators Hub.

C. Key Technical Levels:

• Immediate Technical Support: ₹8,550 – ₹8,650 (20-Day EMA Zone).
• Major Structural Support: ₹8,250 – ₹8,350 (50-Day EMA Baseline).
• Immediate Resistance Target: ₹9,326.80 (52-Week High).
• Long-Term Price Target: ₹9,800 – ₹10,200 (Fibonacci Expansion Target).

Valuation Benchmarking vs. Hospital Peers

🔥 Valuation Insight: Trading at ~59.5x P/E, Apollo Hospitals commands a premium valuation justified by its market leadership, 10,000+ bed scale, superior ARPOB (~₹59,500/day), and value-unlocking potential from the upcoming Apollo HealthCo demerger.

Key Growth Catalysts & Future Projections (2026 – 2030)

1. 5,800+ Bed Capacity Expansion: Increasing total operational beds by over 55% will drive long-term revenue growth across inpatient services.
2. Apollo HealthCo Profitability & Listing: Achieving full profitability in Apollo 24/7 digital health operations while preparing for a Q4 FY27 demerger offers potential value realization for shareholders.
3. Rising Medical Value Travel (MVT): Expanding International Patient Care divisions to capture demand for complex surgeries from the Middle East, South Asia, and Africa.

SWOT Analysis & Risk Management Framework